Twin Capital Management Inc. lessened its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 13.8% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,751 shares of the financial services provider's stock after selling 1,883 shares during the quarter. Twin Capital Management Inc.'s holdings in CME Group were worth $3,117,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of CME. Vanguard Group Inc. raised its position in shares of CME Group by 1.0% during the 4th quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider's stock valued at $7,952,273,000 after acquiring an additional 326,623 shares in the last quarter. Geode Capital Management LLC raised its position in shares of CME Group by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider's stock valued at $1,946,717,000 after acquiring an additional 104,697 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of CME Group by 89.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock valued at $1,923,047,000 after acquiring an additional 3,921,278 shares in the last quarter. Norges Bank acquired a new stake in shares of CME Group during the 4th quarter valued at approximately $1,107,389,000. Finally, FIL Ltd raised its position in shares of CME Group by 1.5% during the 4th quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider's stock valued at $947,821,000 after acquiring an additional 61,908 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.
Insider Buying and Selling
In related news, Director William R. Shepard purchased 256 shares of CME Group stock in a transaction that occurred on Wednesday, June 25th. The shares were acquired at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the transaction, the director directly owned 258,196 shares in the company, valued at approximately $69,849,763.88. This represents a 0.10% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, General Counsel Jonathan L. Marcus sold 390 shares of the company's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $277.50, for a total value of $108,225.00. Following the completion of the sale, the general counsel directly owned 6,708 shares of the company's stock, valued at approximately $1,861,470. This trade represents a 5.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 13,400 shares of company stock worth $3,680,610 in the last three months. Company insiders own 0.30% of the company's stock.
CME Group Trading Down 1.1%
NASDAQ:CME opened at $274.70 on Friday. The company's 50 day moving average is $275.89 and its 200-day moving average is $260.85. The firm has a market cap of $98.99 billion, a price-to-earnings ratio of 27.64, a P/E/G ratio of 4.81 and a beta of 0.44. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 12 month low of $193.25 and a 12 month high of $290.79.
CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The firm had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the previous year, the company posted $2.50 earnings per share. The company's quarterly revenue was up 10.4% compared to the same quarter last year. Equities analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were paid a $1.25 dividend. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.82%. CME Group's dividend payout ratio is presently 50.30%.
Analyst Ratings Changes
Several research firms have recently commented on CME. Wall Street Zen lowered shares of CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Keefe, Bruyette & Woods upped their price target on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a research note on Thursday, April 24th. Morgan Stanley raised their price objective on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research report on Thursday, April 24th. Oppenheimer raised their price objective on shares of CME Group from $282.00 to $300.00 and gave the company an "outperform" rating in a research report on Wednesday, June 4th. Finally, Bank of America raised their price objective on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research report on Wednesday, April 2nd. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $261.80.
Check Out Our Latest Stock Report on CME
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
